Healthcare -
Biotechnology - NASDAQ - US
$ 56.615
-1.5 %
$ 10.9 B
Market Cap
20.47
P/E
BMRN - CASH FROM OPERATIONS
Cash from Operations BMRN - BioMarin Pharmaceutical Inc.
573 M
LAST VALUE
80.46%
2 YEAR CAGR
64.02%
5 YEAR CAGR
25.63%
10 YEAR CAGR